This post was originally published on this site
The shifting economic systems and unpredictable labor market have had an effect on the most unexpected of industries. Genetic testing company 23andMe has announced layoffs at its organization, with plans to bring down its workforce by 40%. As a result, the workforce cuts will affect around 200 employees.
23andMe is in pursuit of a strategic shift away from its research business wing and the development of new therapies, and will instead focus its attention on genetic testing and selling its existing products.&n
bsp; Image: Freepik 23andMe Layoffs Announced—The Genetic Testing Business Is a Tough Nut to Crack Considering a 40% reduction